Uppsala, Sweden

Bo F Oberg

This inventor holds 8 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Medivir Ab, Other. Active years: 1993-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bo F Oberg. Retrieved from https://idiyas.com/inventor/bo-f-oberg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 

% Patents Active = 100.0


Average Co-Inventor Count = 3.0

ph-index = 5

Forward Citations = 56(Granted Patents)


Location History:

  • 52 Uppsala, SE (1996)
  • Upsala, SE (1995 - 1997)
  • Uppsala, SE (1993 - 2002)

Company Filing History:


Years Active: 1993-2002

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovative Mind of Bo F Oberg

Introduction

Bo F Oberg, an accomplished inventor based in Uppsala, Sweden, has made significant contributions to the field of pharmaceuticals through his innovative research and patent developments. With a total of seven patents to his name, Oberg's work is primarily focused on substances that exhibit anti-retroviral activity, crucial in the fight against viral infections.

Latest Patents

Oberg's latest patents include groundbreaking work on the anti-retroviral activity of 2′,3′-dideoxy-3′-fluoronucleosides. His research has led to the development of derivatives of purine and a range of antivirally active compounds that have substantial implications for treating various viral infections, including AIDS. These compounds are characterized by a complex formula (I) featuring various amino, hydroxy, and halogen substitutions, alongside detailed processes for their preparation, pharmaceutical compositions, and methods for the treatment of virus infections.

Career Highlights

As a prominent figure at Medivir AB, Oberg has carved out a reputable career in the pharmaceutical industry, focusing on the development of medications fighting retroviral diseases. His work not only emphasizes the creation of new antiviral compounds but also enhances existing treatments by discovering novel mechanisms of action and applications.

Collaborations

Throughout his career, Bo F Oberg has collaborated with esteemed colleagues, including Karl N Johansson and Roelf Datema. These partnerships have facilitated the sharing of ideas and expertise, furthering innovation in antiviral research and leading to the successful development of effective pharmaceutical solutions.

Conclusion

Bo F Oberg's inventive spirit and dedication to his work have positioned him as an influential figure in pharmaceutical innovation. With his continued research and commitment to advancing anti-retroviral therapies, Oberg’s contributions stand to significantly impact public health and the treatment of viral infections worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…